Patents
Patents for C07K 1 - General processes for the preparation of peptides (51,718)
01/2001
01/11/2001WO2001002332A2 Process for the preparation of 3,3-dimethylbutanal
01/11/2001WO2001002075A1 Method for using laser light to control crystal form
01/11/2001DE19943921C1 Separator employing series of finely-porus adsorbent membranes, allows portion of fluid and all particles contained, to bypass each layer through large perforations made in membranes
01/11/2001CA2376198A1 Method for using laser light to control crystal form
01/10/2001EP1067136A1 New peptide derivatives
01/10/2001EP1066328A1 Chimeric protein containing an intramolecular chaperone-like sequence and its application to insulin production
01/10/2001EP1066295A2 Synthesis of compounds and libraries of compounds
01/10/2001EP1066062A1 A method for treating contaminated products and articles
01/10/2001CN2413783Y Polyacrylamide gel horizontal cataphoresis bath
01/10/2001CN1279688A Viral clearance process
01/10/2001CN1279110A In-colon release-controlled thymopeptide capsule and process for extracting and separating thymopeptide
01/09/2001US6172043 Treatments for neurotoxicity in Alzheimer's disease caused by β amyloid peptides
01/09/2001US6171869 Separating polypeptides in liquids; preparing ultrafiltration apparatus, applying polypeptide solution, centrifuging to separate the ion exchange resin with absorbed ions from the polypeptide, recover polypeptides
01/09/2001US6171819 Acyl transfer with stabilized transition complex using catalyst with catalytic imidazole (e.g. histidine) function
01/09/2001US6171807 Mixing together endotoxin neutralizing protein, urea, and fluorescein n-hydroxysuccinimide ester in an aqueous citrate buffer solution, and isolating the labeled protein; for use in testing
01/09/2001US6171783 Detecting parainfluenza virus-3 and respiratory syncytial virus infection by using fusion protein of antigenic proteins from both viruses
01/09/2001US6171614 Reductive amination; liposomes
01/09/2001US6171577 Accessible sulfhydryl group; and hexose moiety recognized by a mammalian liver receptor, wherein the hexose moiety is conjugated to the annexin.
01/09/2001US6171555 Reaction block docking station
01/09/2001CA2204640C Conjugates of bdnf and nt-3 with a water-soluble polymer
01/04/2001WO2001001140A1 Epitopes formed by non-covalent association of conjugates
01/04/2001WO2001000830A1 Sgip peptides
01/04/2001WO2001000668A1 Extraction of integral membrane proteins
01/04/2001WO2001000665A2 Inhibitors of memapsin 2 and use thereof
01/04/2001WO2001000663A2 Catalytically active recombinant memapsin and methods of use thereof
01/04/2001WO2001000654A2 Purification and stabilization of peptide and proteins in pharmaceutical agents
01/04/2001WO2001000247A1 Peptide-lipid conjugates, liposomes and liposomal drug delivery
01/04/2001WO2000061069A3 Methods and compositions for use in the treatment of hyperlipidemia
01/04/2001WO2000051721A3 Combinatorial chelator array
01/04/2001WO2000029617A9 Water-soluble luminescent quantum dots and bioconjugates thereof
01/04/2001CA2377721A1 Sgip peptides
01/04/2001CA2377204A1 Purification and stabilization of peptide and protein pharmaceutical agents
01/04/2001CA2376859A1 Peptide-lipid conjugates, liposomes and liposomal drug delivery
01/04/2001CA2374610A1 Catalytically active recombinant memapsin and methods of use thereof
01/03/2001EP1064951A2 Erythropoietin derivatives
01/03/2001EP1064312A1 Quaternary ammonium polymer, its preparation, its use for separating biomolecules
01/03/2001EP1064300A1 Peptide turn mimetics
01/03/2001EP1064066A1 Adsorption chromatography
01/03/2001EP1064013A1 $i(IN VITRO) FORMATION OF CONGOPHILIC MALTESE-CROSS AMYLOID PLAQUES TO IDENTIFY ANTI-PLAQUE THERAPEUTICS FOR THE TREATMENT OF ALZHEIMER'S AND PRION DISEASES
01/03/2001EP0910467B1 Electrochemical solid phase synthesis of polymers
01/03/2001EP0816506B1 System for the expression of heterologous antigens as fusion proteins
01/03/2001CN1278791A Process for the preparation of azacyclkylalkanoyl pseudotetrapeptides
01/03/2001CN1278530A Novel peptide derivative
01/03/2001CN1060216C Improved methods for the preparation of endotoxinbinding proteins
01/02/2001US6169072 Cyclic adhesion inhibitors
01/02/2001US6168933 Nucleotide sequences coding a transport protein; for the classification, diagnosis, prevention, and treatment of defects in cell proliferation, lipid metabolism and transport
01/02/2001US6168913 Coding combinatorial libraries with fluorine tags
01/02/2001US6168786 Chimeric protein containing a protein of parainfluenza virus (piv-3) and a protein of respiratory syncytial virus (rsv); capable of protecting infants and similar susceptible individuals against diseases caused by both piv and rsv
01/02/2001CA2171832C Alpha1-acid glycoprotein purification process and product
01/02/2001CA2114156C Elucidation and synthesis of selected pentapeptides
01/02/2001CA2019218C Magnetic protein conjugates, a process for the preparation thereof and the use thereof
12/2000
12/28/2000WO2000079001A1 Means for identifying a novel class of genes resistant to the rice yellow mottle virus and the locus of a major gene of resistance to the virus, and their applications
12/28/2000WO2000078807A1 Purified antigen for alzheimer's disease, and methods of obtaining and using same
12/28/2000WO2000078792A1 Method for purification of proteins
12/28/2000WO2000078791A2 FUNCTIONAL POLY-α-AMINOACID DERIVATIVES USEFUL FOR THE MODIFICATION OF BIOLOGICALLY ACTIVE MATERIALS AND THEIR APPLICATION
12/28/2000WO2000078445A1 Methods and apparatus for performing array microcrystallizations
12/28/2000WO2000034315A3 Purification of echinocandin cyclopeptide compounds
12/28/2000DE19930253A1 Chamber for two-dimensional electrophoresis using stacked horizontal includes at least two guide members for inserting an isolating element for temporarily separating two gels
12/28/2000CA2386393A1 Purified antigen for alzheimer's disease, and methods of obtaining and using same
12/28/2000CA2377267A1 Functional poly-.alpha.-aminoacid derivatives useful for the modification of biologically active materials and their application
12/27/2000EP1062245A1 Products comprising inactivated yeasts or moulds and active vhh-type antibodies
12/27/2000EP1062239A2 Ribonucleotide polypeptides containing metal
12/27/2000EP1062231A1 Process for the preparation of a tetrapeptide
12/27/2000EP1062230A1 Method for increasing the serum half-life of a biologically active molecule
12/27/2000EP1062229A1 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
12/27/2000EP1062227A2 Method for designing dna-binding proteins of the zinc-finger class
12/26/2000US6166217 Process for the production of alkoxycarbonyldipeptides intermediates in the synthesis of the lisinopril
12/26/2000US6165981 Stabilizing solutions for proteins and peptides
12/26/2000US6165974 Administering an effective dose of a pharmaceutical preparation comprising at least two coagulation factors which are components of a prothrombinase or of a pro-prothrombinase to the patient for the treatment of acute bleeding
12/26/2000US6165778 Apparatus for the turbulence of containers; for generating and screening molecular libraries
12/26/2000US6165760 Amino acid sequence of polypeptide of the glutamyl transfer rna synthetase family; drug screening of bacteriostats and bactericides; vaccines; diagnosis of infections
12/26/2000US6165750 Streptavidin tetramers have at least one monomer containing an amino acid modification that produces a reduced binding affinity for biotin, a modified off-rate, a modified on-rate, or an altered binding enthalpy; bioseparations, drug delivery
12/26/2000US6165730 Amino acid sequences of epitopes; for immunoassay diagnosis and immunogens for vaccines
12/26/2000US6165717 Method of synthesizing diverse collections of oligomers
12/26/2000US6165465 Immunologic enhancement of the somatogenic effect of somatotropin with an antibody
12/26/2000US6165464 Monoclonal antibodies directed to the HER2 receptor
12/26/2000CA2127067C Phosphonic acid derivatives, their preparation process and pharmaceutical compositions containing them
12/21/2000WO2000077712A1 Method for assessing significance of protein identification
12/21/2000WO2000077520A1 Labelling of peptides and proteins
12/21/2000WO2000077194A1 A structured peptide scaffold for displaying turn libraries on phage
12/21/2000WO2000077175A1 Process of expressing and isolating recombinant proteins and recombinant protein products from plants, plant derived tissues or cultured plant cells
12/21/2000WO2000077174A1 Process of expressing and isolating recombinant proteins and recombinant protein products from plants, plant derived tissues or cultured plant cells
12/21/2000WO2000076662A2 Microenabled chemical reaction in microfluidic chips
12/21/2000WO2000052049A3 A method for purifying human growth hormone
12/21/2000WO2000044491A3 Centrifuging apparatus and method for separation of liquid phases and organic synthesis
12/21/2000CA2376392A1 Process of expressing and isolating recombinant proteins and recombinant protein products from plants, plant derived tissues or cultured plant cells
12/21/2000CA2376232A1 A structured peptide scaffold for displaying turn libraries on phage
12/20/2000EP1060377A2 Reagents and methods for protein microsequencing
12/20/2000CN1277615A Protein composition and process for isolating a protein composition from a muscle source
12/19/2000US6162931 Fluorinated xanthene derivatives
12/19/2000US6162903 Immunoglobulin binding proteins derived from L protein and their uses
12/19/2000US6162895 For prolonged control of hyperglycemia
12/19/2000US6162629 Preparing a serine protease solution; eluting protease from column, freeze drying, filtering and recovering protease
12/14/2000WO2000075664A1 Improvements in luminescence polarization assays
12/14/2000WO2000075322A1 Insect monoamine transporter and methods of use thereof
12/14/2000WO2000075318A1 Phospholipid transfer protein
12/14/2000WO2000075183A1 Product from starfish
12/14/2000WO2000075178A1 Novel echinocandin derivatives, method for preparing same and use as antifungal agents
12/14/2000WO2000075173A2 Peptide fragments of colostrinin
12/14/2000WO2000075172A2 FACTOR VIIa INHIBITORS